Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rising Material Costs Burden P&G's Earnings, Spark Price Increases

This article was originally published in The Tan Sheet

Executive Summary

The marketer of Crest and Prilosec OTC takes a $1.5 billion write-down on its appliances business, and faces continuing pressure from commodity costs. The health care segment’s net sales increased 1% to $3.2 billion, but price increases added 3% to the total, the firm said.

You may also be interested in...



P&G Targets $10 Billion In Cost Savings In Four Years

P&G targets $10 billion in cost cuts before October 2016, including cutting $4.5 billion in spending on raw and packaging materials for its products and reducing overhead by $3 billion. The firm also plans to cut 5,700 jobs within 18 months.

P&G Targets $10 Billion In Cost Savings In Four Years

P&G targets $10 billion in cost cuts before October 2016, including cutting $4.5 billion in spending on raw and packaging materials for its products and reducing overhead by $3 billion. The firm also plans to cut 5,700 jobs within 18 months.

P&G To Hike Prices At Least 3%, Expects Others To Follow

Procter & Gamble expects an across-the-board price increase of at least 3%, spurred by higher commodity costs, will prompt its competitors to raise product prices as well.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel